Valle C C, Hacad E, Sudo L S, Garcia-Leme J
Braz J Med Biol Res. 1985;18(3):341-7.
The effect of cortisol (10 and 20 mg kg-1 day-1, sc), indomethacin (2 and 4 mg kg-1 day-1, po) and piroxicam (10 and 20 mg kg-1 day-1, po) on the proliferative component of inflammation was investigated in normal, diabetic, adrenalectomized and diabetic-adrenalectomized rats using the cotton pellet test. Whereas cortisol was equally effective in preventing granulation tissue formation in all groups of animals, indomethacin and piroxicam were much less active in animals with hormonal dysfunctions. Indomethacin and piroxicam reduced thymus weight of normal and diabetic animals as much as cortisol. This was taken to be a strong indication of the effect of these non-steroidal drugs on the adrenal cortex leading to increased secretion of adrenal corticosteroids. We conclude that at least part of the anti-inflammatory effect of indomethacin and piroxicam, in the present experiments, can be ascribed to the release of endogenous corticosteroids. This would explain the decreased sensitivity of adrenalectomized animals to the non-steroidal anti-inflammatory drugs used. An additional component, however, seems to be necessary for the full expression of the anti-inflammatory effect of these drugs, since diabetic animals were also less responsive to them. When both components were absent, as in diabetic-adrenalectomized animals, indomethacin and piroxicam were practically devoid of an anti-inflammatory effect.
采用棉球试验,研究了皮质醇(10和20毫克/千克/天,皮下注射)、吲哚美辛(2和4毫克/千克/天,口服)和吡罗昔康(10和20毫克/千克/天,口服)对正常、糖尿病、肾上腺切除及糖尿病-肾上腺切除大鼠炎症增殖成分的影响。尽管皮质醇在所有动物组中预防肉芽组织形成的效果相同,但吲哚美辛和吡罗昔康在激素功能失调的动物中活性低得多。吲哚美辛和吡罗昔康使正常和糖尿病动物胸腺重量减轻的程度与皮质醇相同。这被视为这些非甾体药物对肾上腺皮质有影响,导致肾上腺皮质激素分泌增加的有力证据。我们得出结论,在本实验中,吲哚美辛和吡罗昔康的抗炎作用至少部分可归因于内源性皮质类固醇的释放。这可以解释肾上腺切除动物对所用非甾体抗炎药的敏感性降低。然而,这些药物抗炎作用的充分发挥似乎还需要一个额外的成分,因为糖尿病动物对它们的反应也较弱。当两种成分都不存在时,如在糖尿病-肾上腺切除动物中,吲哚美辛和吡罗昔康几乎没有抗炎作用。